Long-term Follow-up of CD19-Targeted CAR-T Cells (CTL019) in Pediatric Patients With Relapsed/Refractory ALL

Slideset - Potent and durable antitumor activity seen in pediatric patients with relapsed/refractory ALL.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research